{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:23:25Z","timestamp":1789647805061,"version":"4.0.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jconrel.2024.03.009","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T01:12:31Z","timestamp":1710292351000},"page":"548-565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Engineered nanomicelles inhibit the tumour progression via abrogating the prostaglandin-mediated immunosuppression"],"prefix":"10.1016","volume":"368","author":[{"given":"Poonam","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kajal","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviani","family":"Nardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trishna","family":"Pani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Animesh","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolly","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchira","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragini","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somesh K.","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devashish","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsh","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi Datta","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.V.S.","family":"Deo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veena S.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00facia Helena","family":"Faccioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ujjaini","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avinash","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2024.03.009_bb0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12916-015-0278-7","article-title":"New horizons in tumour microenvironment biology: challenges and opportunities","volume":"13","author":"Chen","year":"2015","journal-title":"BMC Med."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.coi.2014.01.004","article-title":"New insights into cancer immunoediting and its three component phases-elimination, equilibrium and escape","volume":"27","author":"Mittal","year":"2014","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0015","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","article-title":"Therapeutic targeting of the tumour microenvironment","volume":"11","author":"Bejarano","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumour progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0025","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumour immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0030","doi-asserted-by":"crossref","first-page":"aba9772","DOI":"10.1126\/scitranslmed.aba9772","article-title":"Reactivation of the tumour suppressor PTEN by mRNA nanoparticles enhances antitumour immunity in preclinical models","volume":"13","author":"Lin","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202201703","article-title":"Polypyrrole nanoenzymes as tumour microenvironment modulators to reprogram macrophage and potentiate immunotherapy","volume":"9","author":"Zeng","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0040","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jconrel.2023.02.015","article-title":"Vaccine-like nanomedicine for cancer immunotherapy","volume":"355","author":"Yi","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.03.009_bb0045","article-title":"Docetaxel: an update on its molecular mechanisms, therapeutic trajectory and nanotechnology in the treatment of breast, lung and prostate cancer","volume":"60","author":"Imran","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0050","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1158\/1078-0432.CCR-10-0733","article-title":"A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumour bearers","volume":"16","author":"Kodumudi","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0055","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.7150\/thno.73152","article-title":"Docetaxel remodels prostate cancer immune microenvironment and enhances checkpoint inhibitor-based immunotherapy","volume":"12","author":"Ma","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2024.03.009_bb0060","doi-asserted-by":"crossref","first-page":"8324","DOI":"10.1021\/jacs.5b03078","article-title":"A nanoparticle cocktail: temporal release of predefined drug combinations","volume":"137","author":"Pathak","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0065","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.biomaterials.2018.08.062","article-title":"A designer bow-tie combination therapeutic platform: an approach to resistant cancer treatment by simultaneous delivery of cytotoxic and anti-inflammatory agents and radiation","volume":"187","author":"Pathak","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.03.009_bb0070","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1200\/JCO.2017.72.3569","article-title":"Timing of aspirin and other nonsteroidal anti-inflammatory drug use among patients with colorectal cancer in relation to tumour markers and survival","volume":"35","author":"Hua","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0075","article-title":"Neutralizing tumour-promoting inflammation with polypeptide-dexamethasone conjugate for microenvironment modulation and colorectal cancer therapy","volume":"231","author":"Ma","year":"2020","journal-title":"Biomater"},{"key":"10.1016\/j.jconrel.2024.03.009_bb0080","first-page":"4866","article-title":"Therapeutic potential and deleterious effect of glucocorticoids on azoxymethane\/dextran sulfate sodium-induced colorectal cancer in mice","volume":"11","author":"Pu","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0085","doi-asserted-by":"crossref","first-page":"6396","DOI":"10.1021\/acsnano.8b07865","article-title":"Dexamethasone increases cisplatin-loaded nanocarrier delivery and efficacy in metastatic breast cancer by normalizing the tumour microenvironment","volume":"13","author":"Martin","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.03.009_bb0090","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1158\/1078-0432.CCR-0829-3","article-title":"Pretreatment with dexamethasone increases anti-tumour activity of carboplatin and gemcitabine in mice bearing human cancer xenografts: in vivo activity, pharmacokinetics, and clinical implications for cancer chemotherapy","volume":"10","author":"Wang","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0095","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.4103\/0976-500X.120975","article-title":"Corticosteroid-related central nervous system side effects","volume":"4","author":"Ciriaco","year":"2013","journal-title":"J. Pharmacol. Pharmacother."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2018.12.004","article-title":"Enhancing solid tumour therapy with sequential delivery of dexamethasone and docetaxel engineered in a single carrier to overcome stromal resistance","volume":"294","author":"Zhang","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.03.009_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2022.134880","article-title":"Excipient-free prodrug-based three-in-on nanoparticles co-deliver diversified agents to amplify tumour therapy","volume":"435","author":"Zhang","year":"2022","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0110","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.156","article-title":"Many faces of DAMPS in cancer therapy","volume":"4","author":"Krysko","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0115","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1073\/pnas.1602023113","article-title":"PGE2 induced in and released by dying cells functions as an inhibitory DAMP","volume":"113","author":"Hangai","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2024.03.009_bb0120","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1158\/1940-6207.CAPR-22-0038","article-title":"Role of prostaglandin E2 in the progression of gastrointestinal cancer","volume":"15","author":"Wilson","year":"2022","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.jconrel.2024.03.009_bb0125","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1053\/j.gastro.2021.09.059","article-title":"Cyclooxygenases and prostaglandins in tumour immunology and microenvironment of gastrointestinal cancer","volume":"61","author":"Wang","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2024.03.009_bb0130","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3390\/nano11010070","article-title":"Recent advances in nanomicelles delivery systems","volume":"11","author":"Tawfik","year":"2021","journal-title":"Nanomat"},{"key":"10.1016\/j.jconrel.2024.03.009_bb0135","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3389\/fphar.2018.01283","article-title":"Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles","volume":"9","author":"Pavlovic","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0140","doi-asserted-by":"crossref","first-page":"5394","DOI":"10.1002\/anie.202015173","article-title":"Bile-acid-tethered docetaxel-based nanomicelles mitigates the tumour progression via epigenetic changes","volume":"60","author":"Sreekanth","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0145","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2018.167","article-title":"Comprehensive high-resolution multiple-reaction monitoring mass spectrometry for targeted eicosanoid assays","volume":"5","author":"Sorgi","year":"2018","journal-title":"Sci. Data."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0150","unstructured":"A. Kassambara, M. Kosinski, P. Biecek, Survminer: Drawing Survival Curves using 'ggplot2', R package version 0.4.6. https:\/\/CRAN.R-project.org\/package=survminer (2019)."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0155","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.3390\/biomedicines10092055","article-title":"Bioavailability enhancement techniques for poorly aqueous soluble drugs and therapeutics","volume":"10","author":"Bhalani","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jconrel.2024.03.009_bb0160","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrd2468","article-title":"Prodrugs: design and clinical applications","volume":"7","author":"Rautio","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0165","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1080\/10717544.2019.1588424","article-title":"Application and design of esterase-responsive nanoparticles for cancer therapy","volume":"26","author":"Dong","year":"2019","journal-title":"Drug Del."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0170","doi-asserted-by":"crossref","first-page":"18419","DOI":"10.1021\/jacs.2c06877","article-title":"Engineering poly(ethylene glycol) nanoparticles for accelerated blood clearance inhibition and targeted drug delivery","volume":"144","author":"Tian","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0175","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3389\/fphar.2018.01283","article-title":"Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles","volume":"9","author":"Pavlovic","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0180","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1021\/acs.molpharmaceut.1c00455","article-title":"Tumour associated fibroblasts-targeting nanoparticles for enhancing solid tumour therapy: progresses and challenges","volume":"18","author":"Li","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0185","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.3389\/fimmu.2020.01842","article-title":"Analysing one cell at a time: analysis of myeloid cell contributions in the tumour immune microenvironment","volume":"11","author":"Davidov","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0190","doi-asserted-by":"crossref","first-page":"8470","DOI":"10.3390\/ijms22168470","article-title":"Tumour-associated macrophage (TAMs) in colorectal cancer (CRC): from mechanism to therapy and prognosis","volume":"22","author":"Wang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0195","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1106677","article-title":"Phenotyping of tumour-associated macrophages in colorectal cancer: impact on single cell invasion (tumour budding) and clinicopathological outcome","volume":"5","author":"Koelzer","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jconrel.2024.03.009_bb0200","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/149185","article-title":"Chronic inflammation and cytokines in the tumour microenvironment","volume":"2014","author":"Landskron","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jconrel.2024.03.009_bb0205","doi-asserted-by":"crossref","first-page":"11553","DOI":"10.1007\/s13277-016-5098-7","article-title":"Role of interleukin-6 in cancer progression and therapeutic resistance","volume":"37","author":"Kumari","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0210","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s40487-018-0089-z","article-title":"The role of interleukin-1 in the pathogenesis of cancer and its potential as a therapeutic target in clinical practice","volume":"6","author":"Litmanovich","year":"2018","journal-title":"Oncol. Ther."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0215","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1038\/s41598-020-58642-y","article-title":"TNF-\u03b1 increases breast cancer stem-like cells through up-regulating TAZ expression via the non-canonical NF-\u03baB pathway","volume":"10","author":"Liu","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13402-019-00489-1","article-title":"The dual role of tumour necrosis factor-alpha (TNF-\u03b1) in breast cancer: molecular insights and therapeutic approaches","volume":"43","author":"Cruceriu","year":"2020","journal-title":"Cell. Oncol. (Dordr)"},{"key":"10.1016\/j.jconrel.2024.03.009_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2016.64","article-title":"Stimulatory versus suppressive effects of GM-CSF on tumour progression in multiple cancer types","volume":"48","author":"Hong","year":"2016","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0230","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1073\/pnas.1810254116","article-title":"IL-27 confers a protumourigenic activity of regulatory T cells via CD39","volume":"116","author":"Park","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2024.03.009_bb0235","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3389\/fonc.2019.00969","article-title":"IL-27, IL-30 and IL-35: a cytokine triumuriate in cancer","volume":"9","author":"Kourko","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0240","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-021-00566-3","article-title":"Interferon-\u03b3: teammate or opponent in the tumour microenvironment?","volume":"22","author":"Gocher","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0245","doi-asserted-by":"crossref","first-page":"600","DOI":"10.4049\/jimmunol.171.2.600","article-title":"Anti-tumour and antimetastatic activity of IL-23","volume":"171","author":"Lo","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0250","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nature14034","article-title":"Blocking PGE2-induced tumour repopulation abrogates bladder cancer resistance","volume":"517","author":"Kurtova","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2024.03.009_bb0255","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc2809","article-title":"Eicosanoid and cancer","volume":"10","author":"Wang","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2024.03.009_bb0260","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/gut.2004.047100","article-title":"Prostaglandins and cancer","volume":"55","author":"Wang","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2024.03.009_bb0265","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1172\/JCI97953","article-title":"Role of prostanoids in gastrointestinal cancer","volume":"128","author":"Wang","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0270","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1053\/j.gastro.2021.09.059","article-title":"Cyclooxygenases and prostaglandins in tumour immunology and microenvironment of gastrointestinal cancer","volume":"161","author":"Wang","year":"2021","journal-title":"Gastroenter"},{"key":"10.1016\/j.jconrel.2024.03.009_bb0275","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.595498","article-title":"Eicosanoids in cancer: new roles in immunoregulation","volume":"11","author":"Johnson","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0280","first-page":"193","article-title":"A radioimmunoassay for 6-keto-prostaglandin F1 alpha","volume":"6","author":"Demers","year":"1980","journal-title":"Adv. Prostaglandin Thromboxane Res."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0285","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/ijc.22755","article-title":"Prostaglandin F2\u03b1 stimulates motility and invasion in colorectal tumour cells","volume":"121","author":"Qualtrough","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2024.03.009_bb0290","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12935-015-0260-7","article-title":"Cyclooxygenase-2 promotes tumour growth and suppresses tumour immunity","volume":"15","author":"Liu","year":"2015","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0295","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12964-020-0530-4","article-title":"Tumour microenvironment complexity and therapeutic implications at a glance","volume":"18","author":"Baghban","year":"2020","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.jconrel.2024.03.009_bb0300","doi-asserted-by":"crossref","first-page":"17218","DOI":"10.1039\/D1NR05512G","article-title":"Chemotherapeutic drug-induced immunogenic cell death for nanomedicine-based cancer chemo\u2013immunotherapy","volume":"13","author":"Jiang","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2024.03.009_bb0305","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41416-022-01775-w","article-title":"Cancer-inducing niche: the force of chronic inflammation","volume":"127","author":"Afify","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2024.03.009_bb0310","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2024.03.009_bb0315","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.cell.2015.08.015","article-title":"Cyclooxygenase-dependent tumour growth through evasion of immunity","volume":"162","author":"Zelenay","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2024.03.009_bb0320","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1038\/s41467-020-19970-9","article-title":"Tipping the immunostimulatory and inhibitory damp balance to harness immunogenic cell death","volume":"11","author":"Hayashi","year":"2020","journal-title":"Nat. Commun."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924001615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924001615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T16:35:39Z","timestamp":1738082139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924001615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":64,"alternative-id":["S0168365924001615"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.03.009","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered nanomicelles inhibit the tumour progression via abrogating the prostaglandin-mediated immunosuppression","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}